Streetbeat News

Analyst Ratings

HALO

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a 'Buy' rating on Halozyme Therapeutics (NASDAQ:HALO) and maintained a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:06 am

SYNA

Rosenblatt analyst Kevin Cassidy has reiterated a 'Buy' rating on Synaptics (NASDAQ:SYNA) and maintained a price target of $100.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:03 am

LTRX

Needham analyst Ryan Koontz has reiterated a 'Buy' rating on Lantronix (NASDAQ:LTRX) and maintained a price target of $8.5.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:02 am

RPHM

HC Wainwright & Co. analyst Gobind Singh has reiterated a 'Buy' rating on Reneo Pharmaceuticals (NASDAQ:RPHM) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 11:00 am

ZVSA

HC Wainwright & Co. analyst Ed Arce has initiated coverage on ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy rating and a price target of $2.5.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 10:59 am

BTAI

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on BioXcel Therapeutics (NASDAQ:BTAI) and maintained an $11 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 10:58 am

NRIX

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on Nurix Therapeutics (NASDAQ:NRIX) and raises the price target from $33 to $35.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 10:57 am

RANI

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a 'Buy' rating on Rani Therapeutics Hldgs (NASDAQ:RANI) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 10:56 am

PL

Needham analyst Ryan Koontz maintains a Buy rating on Planet Labs (NYSE:PL) but lowers the price target from $8 to $7.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 10:54 am

FRSH

Piper Sandler analyst Brent Bracelin maintains an Overweight rating on Freshworks (NASDAQ:FRSH) and raises the price target from $27 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 9:30 am